New Year Bumper Sale @ Rs. 1 X
Vibite M 500 Tablet (15) is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Geriatric |
|
Is the use of Vibite M 500 Tablet (15) safe for pregnant women?
Vibite M Tablet may cause moderate side effects during pregnancy. If you feel its harmful effects, then stop taking this drug immediately, and do not take Vibite M Tablet again without your doctor's advice.
Is the use of Vibite M 500 Tablet (15) safe during breastfeeding?
Vibite M Tablet does not show any harmful effects in lactating women.
What is the effect of Vibite M 500 Tablet (15) on the Kidneys?
Vibite M Tablet may cause harmful effects on kidney. if you feel its having any such effect, then stop taking this drug, and restart only on your doctor's advice.
What is the effect of Vibite M 500 Tablet (15) on the Liver?
Vibite M Tablet may cause harmful effects on liver. if you feel it's having any such effect, then stop taking this drug, and restart only on your doctor's advice.
What is the effect of Vibite M 500 Tablet (15) on the Heart?
Side effects of Vibite M Tablet on heart are unknown because research on this has not been conducted yet.
Vibite M 500 Tablet (15) should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
If you are suffering from any of the following diseases, you should not take Vibite M 500 Tablet (15) unless your doctor advises you to do so -
Is this Vibite M 500 Tablet (15) habit forming or addictive?
Vibite M 500 Tablet (15) does not cause addiction.
Is it safe to drive or operate heavy machinery when consuming?
After taking Vibite M 500 Tablet (15), you should not drive or work on any heavy machine, as Vibite M 500 Tablet (15) can make you drowsy.
Is it safe?
Yes, but consume Vibite M 500 Tablet (15) only on doctor's advice.
Is it able to treat mental disorders?
There is no benefit of taking Vibite M 500 Tablet (15) for mental disorders.
Interaction between Food and Vibite M 500 Tablet (15)
There isn't any research available on the side effects of taking Vibite M 500 Tablet (15) with food.
Interaction between Alcohol and Vibite M 500 Tablet (15)
Information about the interaction of Vibite M 500 Tablet (15) and alcohol is not currently available because this topic has not been researched yet.
Vibite M Tablet should be taken with food to reduce stomach and bowel side effects, which may experience the first few weeks of treatment. Also, exercise regularly and test for sugar in your blood or urine as directed.
Vibite M Tablet is not a known cause of alopecia (hair loss). However, the conditions treated by Vibite M Tablet type 2 diabetes and PCOS, often list hair loss as a possible symptom.
The long-term use can lead to the deficiency of Vitamin B12, which can further lead to megaloblastic anemia. Furthermore, Long-term Metformin use can also lead to kidney and liver problems.
Yes, Vibite M Tablet commonly cause stomach upset like diarrhea, abdominal pain, nausea, and vomiting. To avoid these side effects you should take Vibite M Tablet with your meal and increase the dose gradually.
No, you should not take alcohol with Vibite M Tablet, because it can cause serious side effects which includes hypoglycemia (low blood sugar). The risk of hypoglycemia is higher when you're drinking and taking Vibite M Tablet than if you're just taking Vibite M Tablet. Some of the signs of hypoglycemia include dizziness, confusion, and drowsiness.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Glucophage® (metformin hydrochloride)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 275-276
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 825-826
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 275